Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Torrent Pharma Inc

Torrent Pharma Inc Recalls

All product recalls associated with Torrent Pharma Inc.

Get alerts for this brand

Recall Summary

Total Recalls

84

Past Year

2

Class I (Serious)

1

Most Recent

May 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 41–60 of 84 recalls

Banophen Oral Solution (Torrent Pharma) – Bacterial Contamination Risk (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Cetirizine HCL Oral Solution (Torrent Pharma) – Potential Contamination (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Laxative Suppositories (Torrent Pharma) – Bacterial Contamination Risk (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Page 3 of 5Next

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Cyproheptadine Syrup (Torrent Pharma) – Bacterial Contamination Risk (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Cough Syrup (Torrent) – bacterial contamination (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Pseudoephedrine Oral Solution (Torrent Pharma) – Bacterial Contamination Risk (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Nasal Decongestant Liquid (Torrent) – bacterial contamination (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Bisacodyl Suppositories (Torrent Pharma) – Potential Contamination (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Hemorrhoidal Suppositories (Torrent) – bacterial contamination (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Kid Kare Cough/Cold Liquid (Torrent) – bacterial contamination (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Allergy Liquid Antihistamine (Torrent Pharma) – Potential Contamination (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Lactulose Solution (Torrent Pharma) – Potential Contamination (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Pedia Relief Cough-Cold Solution (Torrent Pharma) – Potential Contamination (2019)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Class IIModerate

FDAMay 21, 2019Nationwide• Torrent Pharma Inc

Losartan Potassium Tablet (Torrent Pharma) – Impurity Detection (2019)

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Class IIModerate

FDAApr 18, 2019Nationwide• Torrent Pharma Inc.

Losartan/Hydrochlorothiazide Tablet (Torrent Pharma) – Impurity Detection (2019)

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Class IIModerate

FDAApr 18, 2019Nationwide• Torrent Pharma Inc.

Losartan Potassium Tablets (Torrent Pharma) – NMBA Impurity (2019)

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Class IIModerate

FDAApr 18, 2019Nationwide• Torrent Pharma Inc.

Losartan Potassium Tablet (Torrent Pharma) – Impurity Detection (2019)

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Class IIModerate

FDAApr 18, 2019Nationwide• Torrent Pharma Inc.

Losartan Potassium Tablet (Torrent Pharma) – Impurity Detection (2019)

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Class IIModerate

FDAApr 18, 2019Nationwide• Torrent Pharma Inc.

Losartan Hydrochlorothiazide Tablets (Torrent Pharma) – NMBA Impurity (2019)

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Class IIModerate

FDAApr 18, 2019Nationwide• Torrent Pharma Inc.

Losartan Potassium Tablets (Torrent) – Impurity Risk (2019)

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Class IIModerate

FDAFeb 28, 2019Nationwide• Torrent Pharma Inc.